On the Radar…

CaridianBCT announced today that it has been awarded a grant as part of the US Department of Defense (DOD) Deployment Related Medical Research Program (DRMRP) to work on development of Mirasol Pathogen Reduction Technology (PRT) System designed to improve the safety of whole blood transfusions in trauma cases. The Mirasol PRT system uses riboflavin and UV light to reduce infectious pathogens and inactivate white blood cells in collected blood, making it safer for transfusion. The use of riboflavin, which is non-toxic and non-mutagenic, affords the distinct advantage that any residual does not present a hazard to handlers and does not need to be removed prior to transfusion. CaridianBCT, a leading provider of blood collection technology headquartered in Lakewood, Colorado, has collaborated with the DOD previously in the evaluation of blood components (platelets and plasma) after using the Mirasol PRT system.